235 related articles for article (PubMed ID: 12880968)
1. Negative autoregulation of p73 and p53 by DeltaNp73 in regulating differentiation and survival of human neuroblastoma cells.
Nakagawa T; Takahashi M; Ozaki T; Watanabe K; Hayashi S; Hosoda M; Todo S; Nakagawara A
Cancer Lett; 2003 Jul; 197(1-2):105-9. PubMed ID: 12880968
[TBL] [Abstract][Full Text] [Related]
2. DeltaNp73 antisense activates PUMA and induces apoptosis in neuroblastoma cells.
Simões-Wüst AP; Sigrist B; Belyanskaya L; Hopkins Donaldson S; Stahel RA; Zangemeister-Wittke U
J Neurooncol; 2005 Mar; 72(1):29-34. PubMed ID: 15803372
[TBL] [Abstract][Full Text] [Related]
3. Autoinhibitory regulation of p73 by Delta Np73 to modulate cell survival and death through a p73-specific target element within the Delta Np73 promoter.
Nakagawa T; Takahashi M; Ozaki T; Watanabe Ki K; Todo S; Mizuguchi H; Hayakawa T; Nakagawara A
Mol Cell Biol; 2002 Apr; 22(8):2575-85. PubMed ID: 11909952
[TBL] [Abstract][Full Text] [Related]
4. Differential response of p53 target genes to p73 overexpression in SH-SY5Y neuroblastoma cell line.
Goldschneider D; Blanc E; Raguénez G; Barrois M; Legrand A; Le Roux G; Haddada H; Bénard J; Douc-Rasy S
J Cell Sci; 2004 Jan; 117(Pt 2):293-301. PubMed ID: 14676279
[TBL] [Abstract][Full Text] [Related]
5. Cyclooxygenase inhibitors differentially modulate p73 isoforms in neuroblastoma.
Lau LM; Wolter JK; Lau JT; Cheng LS; Smith KM; Hansford LM; Zhang L; Baruchel S; Robinson F; Irwin MS
Oncogene; 2009 May; 28(19):2024-33. PubMed ID: 19363520
[TBL] [Abstract][Full Text] [Related]
6. DeltaNp73, a dominant-negative inhibitor of wild-type p53 and TAp73, is up-regulated in human tumors.
Zaika AI; Slade N; Erster SH; Sansome C; Joseph TW; Pearl M; Chalas E; Moll UM
J Exp Med; 2002 Sep; 196(6):765-80. PubMed ID: 12235210
[TBL] [Abstract][Full Text] [Related]
7. Spatiotemporal switch from DeltaNp73 to TAp73 isoforms during nephrogenesis: impact on differentiation gene expression.
Saifudeen Z; Diavolitsis V; Stefkova J; Dipp S; Fan H; El-Dahr SS
J Biol Chem; 2005 Jun; 280(24):23094-102. PubMed ID: 15805112
[TBL] [Abstract][Full Text] [Related]
8. The neurogene BTG2TIS21/PC3 is transactivated by DeltaNp73alpha via p53 specifically in neuroblastoma cells.
Goldschneider D; Million K; Meiller A; Haddada H; Puisieux A; Bénard J; May E; Douc-Rasy S
J Cell Sci; 2005 Mar; 118(Pt 6):1245-53. PubMed ID: 15741235
[TBL] [Abstract][Full Text] [Related]
9. Possible oncogenic potential of DeltaNp73: a newly identified isoform of human p73.
Ishimoto O; Kawahara C; Enjo K; Obinata M; Nukiwa T; Ikawa S
Cancer Res; 2002 Feb; 62(3):636-41. PubMed ID: 11830511
[TBL] [Abstract][Full Text] [Related]
10. TAp73 and ΔNp73 have opposing roles in 5-aza-2'-deoxycytidine-induced apoptosis in breast cancer cells.
Lai J; Yang F; Zhang W; Wang Y; Xu J; Song W; Huang G; Gu J; Guan X
Mol Cells; 2014 Aug; 37(8):605-12. PubMed ID: 25134538
[TBL] [Abstract][Full Text] [Related]
11. When p53 needs p73 to be functional - forced p73 expression induces nuclear accumulation of endogenous p53 protein.
Goldschneider D; Blanc E; Raguenez G; Haddada H; Bénard J; Douc-Rasy S
Cancer Lett; 2003 Jul; 197(1-2):99-103. PubMed ID: 12880967
[TBL] [Abstract][Full Text] [Related]
12. Mdm2-mediated NEDD8 modification of TAp73 regulates its transactivation function.
Watson IR; Blanch A; Lin DC; Ohh M; Irwin MS
J Biol Chem; 2006 Nov; 281(45):34096-103. PubMed ID: 16980297
[TBL] [Abstract][Full Text] [Related]
13. Mechanism of induction of apoptosis by p73 and its relevance to neuroblastoma biology.
Rossi M; Sayan AE; Terrinoni A; Melino G; Knight RA
Ann N Y Acad Sci; 2004 Dec; 1028():143-9. PubMed ID: 15650240
[TBL] [Abstract][Full Text] [Related]
14. p73 induces apoptosis by different mechanisms.
Ramadan S; Terrinoni A; Catani MV; Sayan AE; Knight RA; Mueller M; Krammer PH; Melino G; Candi E
Biochem Biophys Res Commun; 2005 Jun; 331(3):713-7. PubMed ID: 15865927
[TBL] [Abstract][Full Text] [Related]
15. E1A activates transcription of p73 and Noxa to induce apoptosis.
Flinterman M; Guelen L; Ezzati-Nik S; Killick R; Melino G; Tominaga K; Mymryk JS; Gäken J; Tavassoli M
J Biol Chem; 2005 Feb; 280(7):5945-59. PubMed ID: 15572378
[TBL] [Abstract][Full Text] [Related]
16. Transactivation-dependent and -independent regulation of p73 stability.
Dulloo I; Sabapathy K
J Biol Chem; 2005 Aug; 280(31):28203-14. PubMed ID: 15919663
[TBL] [Abstract][Full Text] [Related]
17. Differential control of TAp73 and DeltaNp73 protein stability by the ring finger ubiquitin ligase PIR2.
Sayan BS; Yang AL; Conforti F; Tucci P; Piro MC; Browne GJ; Agostini M; Bernardini S; Knight RA; Mak TW; Melino G
Proc Natl Acad Sci U S A; 2010 Jul; 107(29):12877-82. PubMed ID: 20615966
[TBL] [Abstract][Full Text] [Related]
18. Differential regulation of p73 variants in response to cisplatin treatment in SH-SY5Y neuroblastoma cells.
Million K; Horvilleur E; Goldschneider D; Agina M; Raguénez G; Tournier F; Bénard J; Douc-Rasy S
Int J Oncol; 2006 Jul; 29(1):147-54. PubMed ID: 16773194
[TBL] [Abstract][Full Text] [Related]
19. Dysregulation of platelet-derived growth factor beta-receptor expression by DeltaNp73 in neuroblastoma.
Wetterskog D; Moshiri A; Ozaki T; Uramoto H; Nakagawara A; Funa K
Mol Cancer Res; 2009 Dec; 7(12):2031-9. PubMed ID: 19952113
[TBL] [Abstract][Full Text] [Related]
20. Differential regulation of p63 and p73 expression.
Waltermann A; Kartasheva NN; Dobbelstein M
Oncogene; 2003 Aug; 22(36):5686-93. PubMed ID: 12944917
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]